NO954414L - Transdermale terapeutiske systemer for administrering av serotonin-agonister - Google Patents

Transdermale terapeutiske systemer for administrering av serotonin-agonister

Info

Publication number
NO954414L
NO954414L NO954414A NO954414A NO954414L NO 954414 L NO954414 L NO 954414L NO 954414 A NO954414 A NO 954414A NO 954414 A NO954414 A NO 954414A NO 954414 L NO954414 L NO 954414L
Authority
NO
Norway
Prior art keywords
administration
transdermal therapeutic
therapeutic systems
serotonin agonists
active substances
Prior art date
Application number
NO954414A
Other languages
English (en)
Other versions
NO954414D0 (no
Inventor
Harald List
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO954414L publication Critical patent/NO954414L/no
Publication of NO954414D0 publication Critical patent/NO954414D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Et transdermalt terapeutisk system for systemisk administrering av virksomme stoffer, som er karak- terisert ved at minst ett av de virksomme stoffer er en serotonin- agonist fra gruppen av indolderiva- ter, f.eks. surnatriptan.
NO954414A 1993-05-06 1995-11-03 Transdermale terapeutiske systemer for administrering av serotonin-agonister NO954414D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (de) 1993-05-06 1993-05-06 Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP1994/001280 WO1994026270A1 (de) 1993-05-06 1994-04-25 Transdermale therapeutische systeme zur verabreichung von serotoninagonisten

Publications (2)

Publication Number Publication Date
NO954414L true NO954414L (no) 1995-11-03
NO954414D0 NO954414D0 (no) 1995-11-03

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954414A NO954414D0 (no) 1993-05-06 1995-11-03 Transdermale terapeutiske systemer for administrering av serotonin-agonister

Country Status (20)

Country Link
EP (1) EP0697869B1 (no)
JP (1) JPH08509749A (no)
KR (1) KR960702306A (no)
AT (1) ATE183392T1 (no)
AU (1) AU686159B2 (no)
CA (1) CA2160776A1 (no)
CZ (1) CZ289395A3 (no)
DE (2) DE4314976C1 (no)
DK (1) DK0697869T3 (no)
ES (1) ES2138659T3 (no)
FI (1) FI955260A (no)
GR (1) GR3031639T3 (no)
HU (1) HUT74865A (no)
IL (1) IL109509A (no)
NO (1) NO954414D0 (no)
NZ (1) NZ265949A (no)
PL (1) PL179353B1 (no)
SK (1) SK138095A3 (no)
WO (1) WO1994026270A1 (no)
ZA (1) ZA942872B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509985A (pt) 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
CA2361552C (en) * 1999-12-14 2010-06-01 Hideakira Yokoyama Drug for alleviating migraine
DK1435945T3 (da) * 2001-06-05 2008-12-01 Ronald Aung-Din Topisk migræne terapi
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
CA2509023C (en) 2002-12-26 2011-05-24 Pozen Inc. Multilayer dosage forms containing nsaids and triptans
WO2004112723A2 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
CA2633588A1 (en) 2005-12-20 2007-08-23 Teikoku Pharma Usa, Inc. Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
CA2650412C (en) 2006-04-13 2016-09-27 Nupathe, Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
AU2009269129B2 (en) 2008-06-30 2015-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
US9211282B2 (en) 2009-09-25 2015-12-15 Dr. Reddy's Laboratories Ltd. Formulations comprising triptan compounds
JP6216151B2 (ja) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 親水性薬物のエマルジョンパッチ
CN107530318A (zh) 2015-03-02 2018-01-02 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
WO1992000103A1 (en) * 1990-06-28 1992-01-09 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
DK0697869T3 (da) 2000-03-20
NZ265949A (en) 1997-10-24
ZA942872B (en) 1995-07-06
EP0697869B1 (de) 1999-08-18
DE4314976C1 (de) 1994-10-06
AU6648094A (en) 1994-12-12
JPH08509749A (ja) 1996-10-15
ATE183392T1 (de) 1999-09-15
HU9503167D0 (en) 1996-01-29
IL109509A (en) 1999-12-22
CA2160776A1 (en) 1994-11-24
NO954414D0 (no) 1995-11-03
EP0697869A1 (de) 1996-02-28
KR960702306A (ko) 1996-04-27
PL311591A1 (en) 1996-02-19
CZ289395A3 (en) 1996-04-17
AU686159B2 (en) 1998-02-05
IL109509A0 (en) 1994-08-26
FI955260A0 (fi) 1995-11-02
FI955260A (fi) 1995-11-17
GR3031639T3 (en) 2000-02-29
SK138095A3 (en) 1996-06-05
DE59408643D1 (de) 1999-09-23
ES2138659T3 (es) 2000-01-16
HUT74865A (en) 1997-02-28
PL179353B1 (en) 2000-08-31
WO1994026270A1 (de) 1994-11-24

Similar Documents

Publication Publication Date Title
NO954414L (no) Transdermale terapeutiske systemer for administrering av serotonin-agonister
MX9207263A (es) Sistema para el suministro de una substancia activa para la liberacion sostenida.
FI930862A (fi) En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
ATE220896T1 (de) Hydrogelformulierung mit gesteuerter freisetzung
NO911260L (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
FI943280A0 (fi) Osmoosiin perustuva laite ja lääkkeen annon viivytetty aktivointi sen avulla
AU4989997A (en) Soluble form osmotic dose delivery system
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
MX9203755A (es) Dispositivo de suministro iontoforetico de drogas o agentes terapeuticos, dotado de un adhesivo de electrotransporte.
NO943762L (no) Indolderivater som 5-HT 1 agonister
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
DK0825857T3 (da) Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse
NO954287D0 (no) Anvendelse av indolderivater som 5-HT1 agonister
DK1044064T3 (da) Overtrækningsindretning til granula til indtagelse ad oral vej
NO975140D0 (no) Transdermalt terapeutisk system (TTS) for administrasjon av testosteron
NO306113B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NO305836B1 (no) Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
ATE211383T1 (de) Topische aciclovir-zubereitung
DK0456792T3 (da) Forbedret transdermalt system til indgivelse af farmakologisk aktive forbindelser under pH-kontrollerede betingelser
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.
SI0697869T1 (en) Transdermal therapeutic systems for the administration of serotonin agonists
DE69615340D1 (de) Antimykotische zusammensetzung welche crotamiton und salicylaldehyd enthält
TR199800488T1 (xx) Diskinezi i�in 5-HT3 resept�r antagonistleri.
IT8820575A0 (it) Apparecchio per la erogazione di sostanze nebulizzate.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application